CIK: 0001608126 · Show all filings
Period: Q4 2023 (← Previous) (Next →)
Filing Date: Feb 13, 2024
Total Value ($000): $316,969 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | 431,693 | $36,042 | 11.4% | $39.39 | -8.1% | COM NEW | 23282W605 |
| — | SPIRIT AIRLINES INC | 1,700,000 | $27,863 | 8.8% | — | — | Call | 848577102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 769,653 | $24,098 | 7.6% | $19.38 | +23.2% | COM | 004225108 |
| FOLD | AMICUS THERAPEUTICS INC | 1,489,025 | $21,129 | 6.7% | $8.83 | +28.7% | COM | 03152W109 |
| ARVN | ARVINAS INC | 504,700 | $20,773 | 6.6% | $42.02 | -44.4% | COM | 04335A105 |
| ASND | ASCENDIS PHARMA A/S | 163,772 | $20,627 | 6.5% | $89.38 | — | SPONSORED ADR | 04351P101 |
| — | SPRINGWORKS THERAPEUTICS INC | 556,928 | $20,328 | 6.4% | $13.68 | — | COM | 85205L107 |
| — | HOME PLATE ACQUISITION CORP | 331,416 | $20,014 | 6.3% | $0.60 | — | *W EXP 09/30/202 | 43734R111 |
| GLPG | GALAPAGOS NV | 458,659 | $18,644 | 5.9% | $47.20 | — | SPON ADR | 36315X101 |
| RVMD | REVOLUTION MEDICINES INC | 617,100 | $17,698 | 5.6% | $27.92 | -14.0% | COM | 76155X100 |
| LBRDK | LIBERTY BROADBAND CORP | 184,460 | $14,866 | 4.7% | $78.60 | 0.0% | COM SER C | 530307305 |
| RLAY | RELAY THERAPEUTICS INC | 1,317,870 | $14,510 | 4.6% | $14.33 | -41.1% | COM | 75943R102 |
| — | MORPHIC HOLDING INC | 496,856 | $14,349 | 4.5% | $44.89 | — | COM | 61775R105 |
| SRPT | SAREPTA THERAPEUTICS INC | 145,357 | $14,017 | 4.4% | $115.73 | -17.1% | COM | 803607100 |
| TVTX | TRAVERE THERAPEUTICS INC | 1,435,321 | $12,904 | 4.1% | $17.56 | -58.5% | COM | 89422G107 |
| PRTA | PROTHENA CORP PLC | 349,300 | $12,694 | 4.0% | $33.98 | +13.3% | SHS | G72800108 |
| SLDB | SOLID BIOSCIENCES INC | 961,251 | $5,902 | 1.9% | $5.95 | -46.2% | COM NEW | 83422E204 |
| — | CALIDI BIOTHERAPEUTICS INC | 125,000 | $189 | 0.1% | $3.33 | — | COM NEW | 320703101 |
| — | CHURCHILL CAPITAL CORP VII | 548,000 | $71 | 0.0% | $0.92 | — | *W EXP 02/29/202 | 17144M110 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 895,000 | $63 | 0.0% | $43.35 | +18.9% | CLASS A ORD | 61559X104 |
| CNDAW | CONCORD ACQUISITION CORP II | 408,333 | $53 | 0.0% | $0.95 | — | *W EXP 99/99/999 | 20607U116 |
| CLDWW | CALIDI BIOTHERAPEUTICS INC | 655,200 | $33 | 0.0% | $0.50 | — | *W EXP 03/14/202 | 320703119 |
| — | ROSS ACQUISITION CORP II | 439,666 | $25 | 0.0% | $0.89 | — | *W EXP 02/01/202 | G7641C114 |
| CDAWF | COMPASS DIGITAL ACQUISITION CORP | 459,906 | $22 | 0.0% | $0.76 | — | *W EXP 09/29/202 | G2476C123 |
| — | MARBLEGATE ACQUISITION CORP | 735,000 | $22 | 0.0% | $0.50 | — | *W EXP 08/31/202 | 56608A113 |
| IVCPW | SWIFTMERGE ACQUISITION CORP | 490,000 | $20 | 0.0% | $0.21 | — | *W EXP 12/13/202 | G63836111 |
| LSBWF | YS BIOPHARMA CO LTD | 489,999 | $13 | 0.0% | $0.16 | — | *W EXP 03/15/202 | G9845F117 |